Residual internal limiting membrane in epiretinal membrane surgery

British Journal of Ophthalmology

Volumn 93, Issue 8, 2009, Pages 1016-1019

  Kifuku, K ^a   Hata, Y ^a   Kohno, R I ^a   Kawahara, S ^a   Mochizuki, Y ^a   Enaida, H ^a   Sonoda, K H ^a   Ishibashi, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRILLIANT BLUE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EPIRETINAL MEMBRANE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; VISUAL ACUITY; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; EPIRETINAL MEMBRANE; FEMALE; HUMANS; INDICATORS AND REAGENTS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROSANILINE DYES; VISUAL ACUITY; VITRECTOMY;

EID: 68049085461     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.150623     Document Type: Article

References (25)

1. Machemer R. A new concept for vitreous surgery. 7. Two instrument techniques in pars plana vitrectomy. Arch Ophthalmol 1974;92:407-412
2. Park DW, Dugel PU, Garda J, et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology 2003;110:62-64 (Pubitemid 36068727)
3. Grewing R, Mester U. Results of surgery for epiretinal membranes and their recurrences. Br J Ophthalmol 1996;80:323-326 (Pubitemid 26113583)
4. Kwok AK, Lai TY, Yuen KS. Epiretinal membrane surgery with or without internal limiting membrane peeling. Clin Exp Ophthalmol 2005;33:379-385 (Pubitemid 44144608)
5. Maguire AM, Smiddy WE, Nanda SK, et al. Clinicopathologic correlation of recurrent epiretinal membranes after previous surgical removal. Retina 1990;10:213-222
6. Kwok AK, Lai TY, Li WW, et al. Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol 2004;138:194-199 (Pubitemid 39037421)
7. Kadonosono K, Itoh N, Uchio E, et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118 (Pubitemid 30643346)
8. Haritoglou C, Gandorfer A, Gass CA, et al. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002;134:836-841 (Pubitemid 35425451)
9. Uemura A, Kanda S, Sakamoto Y, et al. Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2003;136:252-257 (Pubitemid 36904071)
10. Ueno A, Hisatomi T, Enaida H, et al. Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina 2007;27:499-504. (Pubitemid 46624293)
11. Kawahara S, Hata Y, Miura M, et al. Intracellular events in retinal glial cells exposed to ICG and BBG. Invest Ophthalmol Vis Sci 2007;48:4426-4432 (Pubitemid 351260955)
12. Enaida H, Hisatomi T, Hata Y, et al. Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 2006;26:631-636 (Pubitemid 44620362)
13. Gibran SK, Flemming B, Stappler T, et al. Peel and peel again. Br J Ophthalmol 2008;92:373-377
14. Haritoglou C, Schumann RG, Kampik A, et al. Glial cell proliferation under the internal limiting membrane in a patient with cellophane maculopathy. Arch Ophthalmol 2007;125:1301-1302 (Pubitemid 47403050)
15. Okada M, Ogino N, Matsumura M, et al. Histological and immunohistochemical study of idiopathic epiretinal membrane. Ophthalmic Res 1995;27:118-128
16. Schonfeld CL. Hyalocytes inhibit retinal pigment epithelium cell proliferation in vitro. Ger J Ophthalmol 1996;5:224-228
17. Hirayama K, Hata Y, Noda Y, et al. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Invest Ophthalmol Vis Sci 2004;45:3896-3903 (Pubitemid 39411139)
18. Kita T, Hata Y, Kano K, et al. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes 2007;56:231-238 (Pubitemid 46263122)
19. Kita T, Hata Y, Miura M, et al. Functional characteristics of connective tissue growth factor on vitreoretinal cells. Diabetes 2007;56:1421-1428 (Pubitemid 46715616)
20. Kawahara S, Hata Y, Kita T, et al. Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. Diabetes 2008;57:2784-2793
21. Sebag J. Surgical anatomy of vitreous and the vitreo-retinal interface. In: Tasman W, Jaeger EA, eds. Clinical ophthalmology. Vol 6, Chapter 51. Philadelphia: JB Lippincott, 1994.
22. Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreoretinal disease. Review. Graefes Arch Clin Exp Ophthalmol 2004;242:690-698 (Pubitemid 39242846)
23. Sebag J, Gupta P, Rosen RR, et al. Macular holes and macular pucker: the role of vitreoschisis as imaged by optical coherence tomography/scanning laser ophthalmoscopy. Trans Am Ophthalmol Soc 2007;105:121-9; discusion 129-131 (Pubitemid 352031802)
24. Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol 2008;246:329-332
25. Yamashita T, Uemura A, Sakamoto T. Intraoperative characteristics of the posterior vitreous cortex in patients with epiretinal membrane. Graefes Arch Clin Exp Ophthalmol 2008;246:333-337